Page 132 - Read Online
P. 132

Page 126                                         Chan et al. J Transl Genet Genom 2024;8:13-34  https://dx.doi.org/10.20517/jtgg.2023.36































                Figure 3. A conceptual framework indicating the decline in beta-cell function due to natural aging, metabolic stress, and inflammation
                (e.g., obesity, use of tobacco, psychosocial stress, poor sleep, infection), which can influence the age of onset of diabetes. For a given
                trajectory of beta-cell function, those with reduced beta-cell capacity are more likely to decompensate early. With the onset of
                diabetes, ongoing lipoglucotoxicity and inflammation can further accelerate beta-cell loss, resulting in insulin requirement. Reducing
                metabolic stress, especially in people with vulnerable beta-cell function, may delay the onset of diabetes and insulin requirement [128] .

               2.3% in patients with LADA versus 0.7% in those without autoantibodies, calling for early detection of
               LADA to avoid delayed insulin treatment [124,125] .


               Between 1995 and 1998, fasting, stimulated, and random CPs were measured in 280,539 inhabitants in
               Skaraborg from Sweden, of whom 3.2% had diabetes. Amongst 1,093 patients with well-defined diabetes
               types, all three CP measurement protocols were robust in discriminating type 1 from type 2 diabetes, based
               on receiver operator curve (ROC) analysis, with random CP having the best performance. The optimal cut-
               off value was 0.50 nmol/L for random CP, 0.42 nmol/L for fasting CP, and 0.60 nmol/L for stimulated
                  [126]
               CP . Other researchers proposed using fasting plasma CP < 250 pmol/L with or without autoantibodies to
               indicate absolute or severe insulin deficiency . In our prospective analysis, Chinese patients with type 2
                                                      [46]
               diabetes who had GADA positivity and low CP had the fastest progression rate to insulin treatment with a
               high risk of severe hypoglycemia. These patients should benefit from a basal-bolus insulin regimen to
               optimize glycemic control. Patients with GADA but residual CP level had a similar risk of insulin
               requirement as their peers without autoimmune type 2 diabetes. Counter-intuitively, patients with high CP,
                                                                                   [125]
               suggestive of insulin resistance, were more likely to progress to insulin treatment . In a cohort of Chinese
               of working age, we used fasting plasma CP and glucose to derive Homeostasis model of assessment insulin
               resistance (HOMA-IR) and HOMA-beta to estimate insulin resistance and deficiency. In keeping with their
               contributory roles in diabetes , both HOMA-IR and HOMA-beta predicted incident diabetes in people
                                         [127]
               with normal glucose tolerance. In patients with YOD, these indexes independently predicted early insulin
               requirement . Due to these non-linear relationships of CP, the estimation of HOMA-IR and HOMA-beta,
                          [128]
               which takes prevailing PG into consideration, should be more informative. The use of HOMA indexes and
               autoantibodies will help physicians make more precise diagnoses and treatments.
   127   128   129   130   131   132   133   134   135   136   137